Skip to main content
NOVAREX Co., Ltd. logo

NOVAREX Co., Ltd. — Investor Relations & Filings

Ticker · 194700 ISIN · KR7194700001 KO Manufacturing
Open in API
Filings indexed 335 across all filing types
Latest filing 2025-08-20 AGM Information
Country KR South Korea
Listing KO 194700

About NOVAREX Co., Ltd.

https://www.novarex.co.kr/en/

NOVAREX Co., Ltd. is a research and development-driven company specializing in health functional foods and supplements. It operates as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM), offering end-to-end services that encompass product planning, development, manufacturing, and delivery. Through its Life Science Research Center, the company develops novel functional ingredients validated by thorough verification and human application testing. NOVAREX manufactures a diverse range of product formulations, including tablets, capsules, powders, and stick jellies. A key competitive advantage is its extensive portfolio of individually recognized raw materials, underscoring its focus on scientific innovation and quality.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of Extraordinary General Meeting' (임시주주총회소집공고) for Novarex Co., Ltd. It includes the meeting agenda, date, location, and detailed management information such as board activities, remuneration, and major shareholder transactions, which are standard components of a Proxy Statement (PSI) in the Korean regulatory context (often filed as a '주주총회소집공고' or '사업보고서' related disclosure). Since it is a formal solicitation of shareholder votes and provides the necessary information for the upcoming meeting, it is classified as a Proxy Solicitation & Information Statement.
2025-08-20 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Novarex' (주식회사 노바렉스) for the period ending June 30, 2025. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the sale of shares by an executive (Park Jong Hwa) of Novarex. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2025-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details changes in share ownership by the company's largest shareholder and related parties, including specific transaction dates, volumes, and methods (market buying/selling). This type of filing is a standard regulatory requirement for significant ownership changes, which falls under the 'Major Shareholding Notification' category.
2025-07-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details personal share transactions (purchases) by a company director (Lee Sang Gu) of Novarex. This falls under the category of 'Director's Dealing' (DIRS), which covers insider trades and changes in share ownership by company executives.
2025-07-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details specific share transactions (purchases) made by an executive (Lee Sang Gu) of Novarex. This type of filing is a standard regulatory disclosure for insider trading/director dealings, which corresponds to the 'Director's Dealing' category.
2025-07-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.